|
[1]
|
Maraka, S. and Kennel, K.A. (2015) Bisphosphonates for the Prevention and Treatment of Osteoporosis. BMJ, 351, h3783. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2017) [J]. 中华骨质疏松和骨矿盐疾病杂志, 2017, 10(5): 413-443.
|
|
[3]
|
Yuan, L.Q., Xiao, L., Dan, X., Peng, Y.Q., Sheng, Z.F., Wu, X.P., et al. (2015) Epidemiology and Management of Osteoporosis in the People’s Republic of China: Current Perspectives. Clinical Interventions in Aging, 10, 1017-1033. [Google Scholar] [CrossRef]
|
|
[4]
|
陶亚军. 骨质疏松药物治疗的研究进展[J]. 医学综述, 2016, 22(9): 1715-1718.
|
|
[5]
|
张倩, 王花欣, 王媛, 等. 中药防治绝经后骨质疏松症的研究进展[J]. 中国骨质疏松杂志, 2020, 26(7): 1083-1088.
|
|
[6]
|
中国老年学学会骨质疏松委员会中医药与骨病学科组. 中医药防治原发性骨质疏松症专家共识[J]. 糖尿病临床, 2016, 10(12): 559-564.
|
|
[7]
|
潘扬, 王天山. 植物山茱萸化学成分的研究概况[J]. 南京中医药大学学报, 1998(1): 61-62.
|
|
[8]
|
张志宏, 邢娜, 彭东辉, 王秋红, 匡海学. 中药抗骨质疏松作用及机制的研究进展[J]. 中国药房, 2021, 32(3): 374-379.
|
|
[9]
|
张华, 魏合伟, 冯新送, 等. 中医对原发性骨质疏松症的认识及辨证施治研究[J]. 中医正骨, 2001, 13(3): 606.
|
|
[10]
|
陈涛. 山茱萸水提液对骨质疏松模型小鼠骨形态学影响[J]. 天津药学, 2003(4): 5-6.
|
|
[11]
|
Zeng, L.P., Xu, X.Z., Rao, H., et al. (2012) Regulation of β-Sitosterol in Duzhongye on Homeostasis of Bone Metabolism. Lishizhen Medicine and Materia Medica Research, 23, 1051-1053.
|
|
[12]
|
Srivastava, S.,Toraldo, G., Weitzmann, M.N., Cenci, S.C. and Pacifici, R. (2001) Estrogen Decreases Osteoclast Formation by Down-Regulating Receptor Activator of nf-κb Ligand (Rankl)-Induced JNK Activation. Journal of Biological Chemistry, 276, 8836-8840. [Google Scholar] [CrossRef]
|
|
[13]
|
和渝斌, 何冰娟, 刘立新, 等. 不同β受体阻滞药对老年男性原发性高血压骨质代谢的影响[J]. 临床药物治疗杂志, 2012(5):13-16.
|
|
[14]
|
Pasco, J.A., Henry, M.J., Sanders, K.M., Kotowicz, M.A., Seeman, E. and Nicholson, G.C. (2004) β-Adrenergic Blockers Reduce the Risk of Fracture Partly by Increasing Bone Mineral Density: Geelong Osteoporosis Study. Journal of Bone and Mineral Research, 19, 19-24. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
彭莉, 李双庆. β2肾上腺素能受体激动剂/拮抗剂对大鼠OB IGF-I受体mRNA表达的影响[J]. 中国骨质疏松杂志, 2014, 20(5): 490-494.
|
|
[16]
|
Wong, R. and Rabie, A. (2010) Effect of Quercetin on Bone Formation. Journal of Orthopaedic Research, 26, 1061-1066. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
黄秋霞, 周后德, 杜巍, 等. 雌二醇和孕酮对人成骨细胞胰岛素受体底物基因表达的时间与剂量依赖性[J]. 中华老年医学杂志, 2005, 24(10): 775-778.
|
|
[18]
|
Yuan, C.Q. and Ding, Z.H. (2002) Activation and Function of Caspases in Apoptosis. Progress in Physiology, 33, 220-224.
|
|
[19]
|
Liu, J., Li, Y. and Geriatrics, D.O. (2015) Effects of Caspase Proteins and Bcl-2 Protein of Osteoblasts on Pathogenesis of Postmenopausal Osteoporosis. Chinese Journal of Joint Surgery (Electronic Edition), 9, 780-783.
|
|
[20]
|
Qi, Z., Li, W., Jiang, L.T., et al. (2016) Effects of Bisphosphonates on the Expression of Bcl-2, Bax and Caspase-3 in Condylar Cartilage of Osteoporosis Rats. Chinese Journal of Tissue Engineering Research, 20, 3970-3976.
|
|
[21]
|
Lane, N.E. and Lukert, B. (1998) The Science and Therapy of Glucocorticoid-Induced Bone Loss. Endocrinology and Metabolism Clinics of North America, 27, 465-483. [Google Scholar] [CrossRef]
|
|
[22]
|
樊长萍, 侯建明. 原发性醛固酮增多症与骨质疏松症的相关性[J]. 中华骨质疏松和骨矿盐疾病杂志, 2016, 9(2): 199-204.
|
|
[23]
|
李靖, 王全平. 细胞凋亡与骨质疏松关系的研究进展[J]. 中华骨科杂志, 2001, 21(5): 305-307.
|
|
[24]
|
谢肇, 李起鸿. 绝经后骨质疏松症的细胞凋亡及其调控机制[J]. 中华老年医学杂志, 2004, 23(6): 436-438.
|